Bridging to China Pharmaceutical and Biotechnology Companies

1. Canada - China Bio/Pharma Bridge
CPhI Shanghai - 2009 Presentation
www.dragonbridgecorp.com

2. Canada - China Bio/Pharma Bridge
• Long history of China – Canada Friendship
• Doctor Norman Bethune - most famous Canadian
• Mark Rowswell (大山 “Dashan”) will be Canada's
Commissioner General for 2010 Shanghai World
Expo
www.dragonbridgecorp.com

3. Canada - China Bio/Pharma Bridge
• Dragonbridge© helps Chinese companies:
– Identify opportunities in Canada
y pp
– Validate potential partners and investments
– Understand legal and regulatory requirements
– Benefit from tax advantages
g
– Find all necessary business resources
– Bridge the cultural and language differences
– Work with Canada to develop fully integrated service ( g
p y g (drug
discovery, development & manufacturing)
www.dragonbridgecorp.com

4. Canada - China Bio/Pharma Bridge
• Quebec Province advantages for Chinese Pharma :
– Almost half of Canadian Bio/Pharma in Quebec
– Most basic & clinical research is in Montreal
– Easier access to Europe and US markets
– New technologies and expertise
– One of the lowest tax rates in North America
– Healthy environment
www.dragonbridgecorp.com

5. Canada - China Bio/Pharma Bridge
• Dragonbridge© helps Canadian companies access
business opportunities in China:
– Demystify China business practices
– Navigate regulatory and legal requirements
g g y g q
– Understand China’s Pharma industry
– Master sourcing in China
– Manufacture and di ib
M f d distribute i Chi
in China
– Localize research in China
– Identify investments or partners
– Monitor best practices and competitors
– Build a solid base for business expansion in China
www.dragonbridgecorp.com

6. Canada - China Bio/Pharma Bridge
• Opportunities for Canadian companies in China:
– Innovation
– Biotechnology
– Sourcing intermediates, APIs, equipment
– Clinical trials, Pre-clinical trials
– Research
– Services
– Distribution
www.dragonbridgecorp.com

7. Canada - China Bio/Pharma Bridge
• Dragonbridge activities:
– Private (Company specific) missions to China
– Consulting on technical issues
– Training in business culture, effective
communication, refining negotiation practices
i ti fi i ti ti ti
– Public missions for senior Pharma and Biotech
executives to assess opportunities in China (15
(
persons maximum)
– Follow-up strategy consulting and implementation
assistance for mission participants
www.dragonbridgecorp.com

8. Canada - China Bio/Pharma Bridge
• Next public Bio/Pharma mission to China for
Canadian firms will be in October 2009.
• Four learning pillars of mission are:
– Scientific
– Operational
– Commercialization
– Investment
www.dragonbridgecorp.com